Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
These interactive case studies are designed to bring the learner to the next level, providing practical scenarios involving patients with real-life medical problems and involving both conventional and cutting-edge solutions.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
This interactive infographic activity will incorporate multiple interactive sections and multimedia formats to provide learners with practical in-depth views and demonstrations of the use of medications and procedures within the nasal anatomy for treating patients with CRS with and without NPs to help them evaluate these current and cutting-edge treatments and consider how to incorporate them into clinical practice.
In this 1.5-hour online educational activity, interprofessional faculty will use patient cases to discuss the clinical effects of neuromuscular blocking and reversal agents, including key components of NMB and reversal during the intraoperative phase of care and neuromuscular monitoring.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
This CMEOCast podcast features expert faculty focusing on best practices to increase vaccine uptake by engaging and educating patients in pharmacy settings.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
The purpose of this initiative is to provide oncology clinicians with a foundation of knowledge about the immune system, particularly the interplay between immune mechanisms and the tumor microenvironment, and how this interplay relates to the mechanisms of action (MOA) of existing immune checkpoint inhibitors, as well as those in development that target novel checkpoints.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
Watch as Dr Michael Overman and Dr Lynette Sholl introduce you to the latest insights into immuno-oncology, discussing current and emerging biomarkers as they relate to clinical practice.
AMA PRA Category 1 Credit(s)TM, AAPA Category I CME credit, ANCC Contact Hour(s), CE for Pharmacists
Outpatient management for alcohol use disorder (AUD) can be a formidable challenge, especially in a patient who is resistant to treatment. Clinicians need to recognize multiple issues, including concerns about comorbidities and drug-drug interactions, when initiating treatment in patients recently referred from the emergency department.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
Educate clinicians who care for patients with RA on the use of serological biomarkers and the guideline-driven assessment of disease severity to determine the appropriate course of disease management.
AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
The current standard of care for localized tenosynovial giant cell tumors (TGCT) is surgical resection. However, diffuse disease often has more extensive involvement and a poorer likelihood of successful cure with surgery, higher risk of recurrence, and substantial morbidity and lower quality of life.
AMA PRA Category 1 Credit(s)TM, AAPA Category I CME credit, ANCC Contact Hour(s), CE for Pharmacists
Alcohol use disorder (AUD) is a chronic disorder that occurs along a spectrum of mild, moderate, and severe disease. Three agents indicated for AUD, as well as several off-label medications, can help patients achieve better overall health outcomes by reducing their alcohol intake.
Join Drs. Arshad M. Khanani and Carl D. Regillo, as they discuss current and emerging strategies for effective and durable treatment of neovascular retinal diseases. The expert faculty will present exciting new data to inform optimal use of currently available intravitreal antivascular endothelial growth factor (anti-VEGF) therapies, as well as the science and surgical techniques related to unprecedented new options for sustained delivery of anti-VEGF therapy that are coming soon.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
Given that patients with diabetes, heart disease, obesity, or other cardiometabolic risk factors are at a high-risk for developing flu-related complications, it is important for clinicians that care for these patients to be aware of the impact of influenza. This webinar, led by 3 experts in the field, will address the latest evidence in influenza treatment and management of patients with chronic cardiometabolic health conditions.
More and more of oncology patients present with multiple co-morbidities, challenges with health literacy and a lack of understanding of how social determinants of health can impact their cancer outcomes. The success of a program depends on its leadership, planning and implementation processes, and the oncology nurse navigators employed in the program.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
Join Karl Lewis, MD, and Aleksandar Sekulic, MD, PhD, as they discuss the importance of the hedgehog pathway in the pathogenesis of BCC and the role of hedgehog inhibitors in advanced BCC.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
This CME Outfitters Snack focuses on recognizing the complex pathogenesis of OA, applying The Osteoarthritis Research Society International (OARSI) guidelines to non-surgical management, and evaluating emerging data in order to set realistic goals with patients and meet unmet needs in the management of OA.
In this activity, expert faculty will present the epidemiologic imperative for HCV treatment as prevention within populations of people who inject drugs (PWID). Potential barriers to treatment of HCV-positive PWID, including outdated clinical assumptions regarding treatment eligibility and prescribing limitations, will be discussed.
Multiple sclerosis (MS) is classically a chronic neurologic disease characterized by attacks of focal neurological deficits secondary to inflammatory, demyelinating plaque(s). A new chapter in the fight against MS starts; now more than ever there is a need to distinguish the subtypes of MS for appropriate evaluation and treatment.
AMA PRA Category 1 Credit(s)TM, NCPD Contact Hour(s), CE for Pharmacists, AAFP Prescribed Credit, ABIM MOC Points
This activity informs providers how to better initiate individualized treatment for patients with type 2 diabetes that are hesitant to insulin initiation. Also reviewed are the most up-to-date insulin therapies and the current challenges and opportunities to improve diabetes care in diverse and underserved patient populations.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
The final installment in this CME Outfitters Snack series on managing OA focuses on best practices for utilizing telehealth, including encouraging patients to maximize mobility in time of isolation, increasing the utilization of video in telehealth and wearable tech, and the consideration of both operative and non-operative measures for treatment.
AMA PRA Category 1 Credit(s)TM, AAFP Prescribed Credit
Using a case study, 3 experts on treating headaches describe the management of migraines in a patient with comorbid cardiovascular disease. They review neuromodulation, lifestyle modifications, and recently approved medications.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
An in-depth review of key clinical trials data on a treat-to-target strategy of care and of the distinguishing features of the new 2020 EULAR RA guidelines and proposed updates to the 2016 ACR RA guidelines.
AMA PRA Category 1 Credit(s)TM, ABIM MOC Credit, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
Two video-based, pre-recorded webinars with presenters who are experts in the field will cover the following topics: Exploring CGM, Identifying Patients Who Will Benefit from CGM , and Emerging Technologies: A Better Life for Patients with Diabetes
In this activity, expert faculty cover the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. The purpose of this activity is to provide learners with an engaging presentation to help them optimize anticoagulant therapy in their patients with PAD post-revascularization.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CDE Credit, CE for Pharmacists
This module shares a methodology, including questionnaires, that will allow you to recognize migraine disease in its many presentations – all within the tight constraints of your busy medical setting.
